These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 6672751)

  • 21. Hyperbaric oxygen and radiotherapy of a fibrosarcoma and of a squamous-cell carcinoma of C3H mice.
    Suit HD; Suchato C
    Radiology; 1967 Oct; 89(4):713-9. PubMed ID: 6059611
    [No Abstract]   [Full Text] [Related]  

  • 22. [Radiosensitizing effects of nitroimidazole derivative, KIN-804].
    Tada T
    Nihon Igaku Hoshasen Gakkai Zasshi; 1995 Jan; 55(1):70-5. PubMed ID: 7899069
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Local administration of radiosensitizer misonidazole].
    Otsuka S; Suda K; Yamashita J; Gi H; Oda Y; Takeuchi J; Handa H; Ono K
    No To Shinkei; 1983 Mar; 35(3):249-55. PubMed ID: 6687999
    [No Abstract]   [Full Text] [Related]  

  • 24. Misonidazole cytotoxicity in vivo: a comparison of large single doses with smaller doses and extended contact of the drug with tumor cells.
    Conroy PJ; Sutherland RM; Passalacqua W
    Radiat Res; 1980 Jul; 83(1):169-89. PubMed ID: 7394163
    [No Abstract]   [Full Text] [Related]  

  • 25. Pilot study of radiotherapy with misonidazole in head and neck cancer.
    Paterson IC; Dawes PJ; Henk JM; Moore JL
    Clin Radiol; 1981 Mar; 32(2):225-9. PubMed ID: 7214840
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Enhancement of radiation response of SqII mouse tumors by combined treatment with misonidazole, vidarabine, and ACNU].
    Asakura H; Akita Y; Kosaka N; Majima H; Suzuki N
    Nihon Igaku Hoshasen Gakkai Zasshi; 1987 Jan; 47(1):74-81. PubMed ID: 3473429
    [No Abstract]   [Full Text] [Related]  

  • 27. Radiosensitizing effect of combined radiotherapy, hyperthermia and misonidazole on C3H mouse FM3A tumor.
    Yamashita M
    Nihon Igaku Hoshasen Gakkai Zasshi; 1984 Sep; 44(9):1181-8. PubMed ID: 6522270
    [No Abstract]   [Full Text] [Related]  

  • 28. Misonidazole dose and tumor level relationships. Effects of individual variation in rate of misonidazole metabolism and absorption from the gastrointestinal tract.
    Strong JM; Schwade JG; Gangji D; Shoemaker DD; Upton DK
    Cancer Clin Trials; 1981; 4(1):41-6. PubMed ID: 7214661
    [No Abstract]   [Full Text] [Related]  

  • 29. Enhancement of antitumor activity of alkylating agents by the radiation sensitizer misonidazole.
    Clement JJ; Gorman MS; Wodinsky I; Catane R; Johnson RK
    Cancer Res; 1980 Nov; 40(11):4165-72. PubMed ID: 7471058
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of hypoxic cell radio-sensitizers in terms of radio-sensitizing and repair-inhibiting potential. Dependency on p53 status of tumor cells and the effects on intratumor quiescent cells.
    Masunaga S; Uto Y; Nagasawa H; Hori H; Nagata K; Suzuki M; Kinashi Y; Ono K
    Anticancer Res; 2006; 26(2A):1261-70. PubMed ID: 16619533
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The use of misonidazole in association with a three-fractions per day regimen in advanced head and neck epidermoid cancer. A pilot study.
    Awwad HK; Barsoum M; El Merzabani M; Omar S; El Badawy S; Ezzat S; El Baki HA; Zaki A
    Am J Clin Oncol; 1983 Feb; 6(1):91-7. PubMed ID: 6301258
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Multiple daily fractionation (MDF) radiotherapy in association with hyperthermia and/or misonidazole: experimental and clinical results.
    Arcangeli G; Barocas A; Mauro F; Nervi C; Spanò M; Tabocchini A
    Cancer; 1980 Jun; 45(11):2707-11. PubMed ID: 7379004
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Palliative topical and systemic misonidazole with low-dose irradiation for recurrent carcinoma of the cervix uteri.
    Hammond A; Sealy R; Welsh D
    Cancer; 1986 Sep; 58(5):1037-9. PubMed ID: 2425927
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Treatment with misonidazole and high voltage irradiation of xenotransplanted human carcinomas in nu/nu mice with thymic aplasia].
    Kleine W; Stange S; Nagy D; Ladner HA
    Strahlentherapie; 1982 Aug; 158(8):498-503. PubMed ID: 6814020
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Clinical evaluation of hypoxic cell sensitizer (Misonidazole)].
    Asakawa H; Watarai J; Hoshino T
    Gan To Kagaku Ryoho; 1984 Jun; 11(6):1225-30. PubMed ID: 6732250
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Radiosensitizing effect of hyperthermia on mouse squamous cell carcinoma.
    Yoshino T
    Fukuoka Igaku Zasshi; 1981 Oct; 72(10):521-31. PubMed ID: 7327497
    [No Abstract]   [Full Text] [Related]  

  • 37. Effects of misonidazole on tumor cell radiation sensitivity and potentially lethal damage repair in vivo and in vitro.
    Sakamoto K; Aritake S
    Eur J Cancer Clin Oncol; 1981 Jul; 17(7):825-30. PubMed ID: 7199475
    [No Abstract]   [Full Text] [Related]  

  • 38. The effect of misonidazole in situ on the radiation response of selected tumor subpopoulations.
    Grdina DJ; Sigdestad CP; Jovonovich JA
    Cancer Clin Trials; 1980; 3(2):149-54. PubMed ID: 7428138
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The effects of uneven fractionated irradiation on mouse squamous cell carcinoma and normal tissue].
    Nemoto K; Sakamoto K
    Nihon Igaku Hoshasen Gakkai Zasshi; 1990 Dec; 50(12):1601-7. PubMed ID: 2089372
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effect of hypoxic radiosensitizer after mild hyperthermia in C3H mammary carcinoma.
    Ohizumi Y; Murayama C; Maezawa H; Mori T
    Tokai J Exp Clin Med; 1984 Oct; 9(4):331-7. PubMed ID: 6537042
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.